Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
38
pubmed:dateCreated
2008-9-1
pubmed:abstractText
Live attenuated influenza vaccine (LAIV) is indicated for influenza prevention in persons 2-49 years of age. This study describes the incidence and duration of vaccine virus shedding and serum immune responses after receipt of LAIV.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0264-410X
pubmed:author
pubmed:issnType
Print
pubmed:day
8
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4940-6
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
pubmed:affiliation
Kentucky Pediatric and Adult Research, Bardstown, KY 40004, United States. slblock@pol.net
pubmed:publicationType
Journal Article, Multicenter Study, Clinical Trial, Phase IV